Hostname: page-component-5c6d5d7d68-lvtdw Total loading time: 0 Render date: 2024-08-21T01:50:21.142Z Has data issue: false hasContentIssue false

Type A7 Coxsackie (type 4 poliomyelitis) virus infection in Scotland

Published online by Cambridge University Press:  15 May 2009

N. R. Grist
Affiliation:
Regional Virus Laboratory, Ruchill Hospital and the UniversityDepartment of Virology, Glasgow
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Coxsackie A 7 virus was isolated from thirty-seven patients during an outbreak in Scotland in 1959. Seven cases were paralytic, one of them fatal. Evidence is presented that Coxsackie A 7 virus caused these paralytic illnesses. The virus was also isolated from a paralytic case in 1956 and from a non-paralytic case in 1961. Serological surveys suggest that it has been active in the community for some years. Specific haemagglutination by Coxsackie A 7 virus was useful for rapid identification of viruses and for measurement of serum antibodies.

I am grateful to Dr A. D. Macrae of the Virus Reference Laboratory, Colindale, London, for prototype Coxsackie A 7 virus; to Dr K. Habel of the National Institutes of Health, Bethesda, U.S.A., for tissue culture-adapted ABIV virus; to Dr J. Wallace of the Blood Transfusion Service, West of Scotland Region, for samples of blood donor sera; to Dr M. Rentsch, Klinik für Kinderkrankheiten, University of Berne, Switzerland, for permission to quote the results of virological tests of his cases; to Miss R. McLelland, F.A.T.A., and to Mr C. McLean F.I.M.L.T., for technical assistance with animal experiments; to Mr H. G. Carson, F.I.M.L.T. and to Mr J. Kerr, A.I.M.L.T., for technical assistance with neutralization tests; and to the many clinical colleagues who provided specimens and information for this study.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1962

References

Chumakov, M. P., Voroshilova, M. K., Zhevandrova, V. I., Mironova, L. L., Itzelis, F. G., & Robinson, I. A. (1956). Probl. Virol. 1, 16.Google Scholar
Combined Scottish Study (1961). Brit. med. J. ii, 597.Google Scholar
Duncan, I. B. R. (1960). Lancet, ii, 470.CrossRefGoogle Scholar
Duncan, I. B. R. (1961). J. Hyg., Camb., 59, 181.CrossRefGoogle Scholar
Duncan, I. B. R. & Sommerville, R. G. (1960). Health Bull. 18, 12.Google Scholar
Grist, N. R. (1960 a). Lancet, i, 1054.CrossRefGoogle Scholar
Grist, N. R. (1960 b). Brit. med. J. i, 344.CrossRefGoogle Scholar
Grist, N. R., Larminie, H. E., MacGregor, L. G., McIntosh, E. G. S., McLaughlin, J. & Sommerville, R. G. (1958). Health Bull. 16, 27.Google Scholar
Grist, N. R., Larminie, H. E., MacGregor, L. G., McIntosh, E. G. S., McLaughlin, J. & Sommerville, R. G. (1960). Scot. med. J. 5, 355.CrossRefGoogle Scholar
Grist, N. R. & Roberts, G. B. S. (1962). J. Path. Bact. 84, 39.CrossRefGoogle Scholar
Habel, K. & Loomis, L. N. (1957). Proc. Soc. exp. Biol., N. Y., 95, 597.CrossRefGoogle Scholar
Johnsson, T. & Lundmark, C. (1957). Lancet, i, 1148.CrossRefGoogle Scholar
Ranzenhofer, E. R., Dizon, F. C., Lipton, M. M. & Steigman, A. J. (1958). New Engl. med. J. 259, 182.CrossRefGoogle Scholar
Rentsch, M. (1961). Rev. Med. Suisse Romande, 81, 433.Google Scholar
Ross, C. A. C. (1961). Lancet, ii, 527.CrossRefGoogle Scholar
Voroshilova, M. K. & Chumakov, M. P. (1959). Prog. med. Virol. 2, 106.Google Scholar